Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
347 - Is the message "Now Approved" acceptable in APS? It seemed that at one time, this was discouraged due to the perception of Health Canada endorsement
-
You are correct. It is generally not accepted as it suggests Health Canada endorsement. This is an application of section C.01.007 of the Food and Drug Regulations which was requested by Health Canada. I said "generally" because there are two exceptions which readily come to mind. On occasion, the wording "approved" appears within a product's Terms of Market Authorization (TMA). In those instances, we accept the message with the same context & emphasis as the TMA. "Approved" / "Approval" can also be considered when its context is limited to formulary coverage.
-
@Jennifer-Carroll @Maryssa My understanding is that "authorized" is accepted, while "approved" is generally not accepted. This is based on PAAB forum topic 191 (PAAB Q&A 501)
-
. However, the copy "Now authorized" alone is incomplete (authorized how? for what?) it should be restricted to "Authorized for use in..." or "Authorized for sale in ...".